Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2020
Biological E acquires Akorn India
Biological E said it acquired Akorn India, which manufactures speciality generic injectable medicines and vaccines, for $10 million in cash. Biological E said the acquisition would enhance its manufacturing capabilities and capacity.
2020
Baylor College of Medicine and Biological E. announce vaccine licensing agreement
Baylor College of Medicine and Biological E. announced a licensing agreement for the development of a COVID-19 vaccine; Biological E. licensed Baylor's recombinant protein vaccine candidate for further development and commercialization.